Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations.
J Thorac Oncol
; 11(4): 545-55, 2016 Apr.
Article
in En
| MEDLINE
| ID: mdl-26773740
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
ErbB Receptors
/
Erlotinib Hydrochloride
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Thorac Oncol
Year:
2016
Document type:
Article
Country of publication:
Estados Unidos